Longitudinal patient-reported performance status assessment in the cancer clinic is feasible and prognostic

Journal of Oncology Practice

Volumn 7, Issue 6, 2011, Pages 374-381

  Suh, Sang Yeon ^a,b   LeBlanc, Thomas W ^a,b   Shelby, Rebecca A ^a,b   Samsa, Gregory P ^a,b   Abernethy, Amy P ^a,b  

^a Dongguk University   (South Korea)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CENTER; CORRELATION ANALYSIS; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NURSE; PATIENT ASSESSMENT; PATIENT CARE; PROGNOSIS; QUALITY OF LIFE; SCORING SYSTEM; SURVIVAL RATE;

EID: 84859450920     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2011.000434     Document Type: Article

References (24)

1. Abernethy AP, Shelby-James T, Fazekas BS, et al: The Australia-modified Karnofsky Performance Status (AKPS) scale: A revised scale for contemporary palliative care clinical practice [ISRCTN81117481]. BMC Palliat Care 4:7, 2005
2. Ganz PA, Haskell CM, Figlin RA, et al: Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the Functional Living Index-Cancer. Cancer 61:849-856, 1988 (Pubitemid 18037942)
3. Mor V, Laliberte L, Morris JN, et al: The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. Cancer 53:2002-2007, 1984
4. Blagden SP Charman SC, Sharples LD, et al: Performance status score: Do patients and their oncologists agree? Br J Cancer 89:1022-1027, 2003 (Pubitemid 37239205)
5. Oken MM, Creech RH, Tormey DC, et al: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655, 1982 (Pubitemid 13149996)
6. Ando M, Ando Y, Hasegawa Y, et al: Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer. Br J Cancer 85:1634-1639, 2001 (Pubitemid 34081505)
7. Schnadig ID, Fromme EK, Loprinzi CL, et al: Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer. Cancer 113:2205-2214, 2008
8. Sorensen, JB Klee M, Palshof T, et al: Performance status assessment in cancer patients: An inter-observer variability study. Br J Cancer 67:773-775, 1993 (Pubitemid 23101557)
9. deBorja M, Chow E, Bovett G, et al: The correlation among patients and health care professionals in assessing functional status using the Karnofsky and Eastern Cooperative Oncology Group performance status scales. Support Cancer Ther, 2:59-63, 2004
10. Abernethy AP, Herndon JE 2nd, Wheeler JL, et al: Feasibility and acceptability to patients of a longitudinal system for evaluating cancer-related symptoms and quality of life: Pilot study of an e/Tablet data-collection system in academic oncology. J Pain Symptom Manage 37:1027-1038, 2009
11. Abernethy AP, Wheeler JL, Zafar SY: Management of gastrointestinal symptoms in advanced cancer patients: The rapid learning cancer clinic model. Curr Opinion Support and Palliat Care 4:36-45, 2010
12. Abernethy AP, Zafar SY, Uronis H, et al: Validation of the Patient Care Monitor (Version 2.0): A review of system assessment instrument for cancer patients. J Pain Symptom Manage 40:545-558, 2010
13. Snyder CF, Blackford AL, Aaronson NK, et al: Can patient-reported outcome measures identify cancer patients' most bothersome issues? J Clin Oncol 29:1216-1220, 2011
14. Gotay CC, Kawamoto CT, Bottomley A, et al: The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol 26:1355-63, 2008
15. Quinten C, Coens C, Mauer M, et al: Baseline quality of life as a prognostic indicator of survival: A meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol 10:865-871, 2009
16. Fortner B, Okon T, Schwartzberg L, et al: The Cancer Care Monitor: Psychometric content evaluation and pilot testing of a computer administered system for symptom screening and quality of life in adult cancer patients. J Pain Symptom Manage 26:1077-1092, 2003 (Pubitemid 37488016)
17. Fortner B, Baldwin S, Schwartzberg L, et al: Validation of the Cancer Care Monitor items for physical symptoms and treatment side effects using expert oncology nurse evaluation. J Pain Symptom Manage 31:207-214, 2006
18. Abernethy AP, Herndon JE 2nd, Wheeler JL, et al: Improving health care efficiency and quality using tablet personal computers to collect research-quality, patient-reported data. Health Serv Res 43:1975-1991, 2008
19. Yellen SB, Cella DF, Webster K, et al: Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13:63-74, 1997 (Pubitemid 27147321)
20. Webster, K, Cella D, Yost K: The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Properties, applications, and interpretation. Health Qual Life Outcomes 1:79, 2003
21. Cella DF, Bonomi AE, Lloyd SR, et al: Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer 12:199-220, 1995
22. Houts, AC, Fortner BV, Schwartzberg L: The Patient Care Monitor (PCM) manual and psychometric information for PCM 1.0, PCM 1.0 Revised, and PCM 2.0. Germantown, TN, Supportive Oncology Services, 2007
23. Brucker PS, Yost K, Cashy J, et al: General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G). Eval Health Prof 28:192-211, 2005 (Pubitemid 40628907)
24. Santana MJ, Au HJ, Dharma-Wardene M, et al: Health-related quality of life measures in routine clinical care: Can FACT-fatigue help to assess the management of fatigue in cancer patients? Int J Technol Assess Health Care 25:90-96, 2009